ATTORNEY GENERAL MCDANIEL SUES ABBOTT AND FOURNIER FOR ILLEGIALLY BLOCKING GENERIC COMPETITION TO TRICOR
LITTLE ROCK- Attorney General Dustin McDaniel announced today that the State of Arkansas has joined 18 other states and the District of Columbia in filing a lawsuit charging Abbott Laboratories and French drug company Fournier with violating antitrust and consumer protection laws. The lawsuit alleges that Abbott Laboratories and Fournier took several actions that delayed the availability of a cheaper, generic version of the drug, TriCor.
The complaint stems from actions taken by Abbott Laboratories and Fournier, which prevented the marketing of a generic version of TriCor. TriCor is Abbott's brand name drug that is used to reduce high levels of triglycerides and cholesterol. As a result of the improper conduct, Abbott Laboratories and Fournier successfully thwarted all generic competition, allowing the companies to charge monopoly prices for TriCor.
"The wrongful actions of these drug companies increased their profits at the expense of the State of Arkansas and its consumers," McDaniel commented. "At a time when drug and health costs are rapidly escalating, these practices cannot be tolerated."
The lawsuit is pending in federal district court in Delaware.